PMID- 23559419 OWN - NLM STAT- MEDLINE DCOM- 20140724 LR - 20191210 IS - 1522-2586 (Electronic) IS - 1053-1807 (Linking) VI - 38 IP - 6 DP - 2013 Dec TI - Validation of sub-segmental visual scoring for the quantification of ischemic and nonischemic myocardial fibrosis using late gadolinium enhancement MRI. PG - 1369-76 LID - 10.1002/jmri.24116 [doi] AB - PURPOSE: To determine the accuracy and reproducibility of late gadolinium enhancement (LGE) MRI scar quantification using visual sub-segmental analysis (VSSA) versus signal threshold-based analysis in ischemic and nonischemic cardiomyopathy. MATERIALS AND METHODS: One-hundred sixty-one patients with abnormal LGE imaging underwent VSSA and signal threshold-based analysis. VSSA was performed using a 68 sub-segmental model. Signal threshold-based analysis was performed using cutoffs of >/=2, >/=3, and >/=5 standard deviations (SD) above the mean signal of normal myocardium. Comparison of VSSA and signal threshold-based analysis was performed by linear regression and Bland Altman plots. RESULTS: Seventy (44%) patients had ischemic scar, 76 (47%) had nonischemic scar, and 15 (9%) had a combined pattern. Correlation coefficients for VSSA versus signal threshold-based analysis at >/=2, >/=3, and >/=5SD thresholds were r = 0.63, r = 0.79, r = 0.81 (P < 0.001) for all patients, r = 0.74, r = 0.81, r = 0.81 (P < 0.001) in those with ischemic scar, and r = 0.46, r = 0.69, r = 0.72 (P < 0.001) in those with nonischemic scar. Bland Altman analysis revealed no significant bias in total scar volume among all patients (-4.3 +/- 7.9%), those with ischemic scar (-4.8 +/- 7.8%), or those with nonischemic scar (-2.6 +/- 7.6%). Intra-observer and inter-observer variability of the VSSA technique was excellent with a mean difference in total percent scar of 0.3% (-8.3-8.9%) and -0.4% (-9.5-8.5%), respectively. CONCLUSION: A VSSA-based model of myocardial scar quantification is accurate and reproducible in ischemic and nonischemic cardiomyopathy. CI - Copyright (c) 2013 Wiley Periodicals, Inc. FAU - Fine, Nowell M AU - Fine NM AD - Division of Cardiology, Department of Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada. FAU - Tandon, Shruti AU - Tandon S FAU - Kim, Han W AU - Kim HW FAU - Shah, Dipan J AU - Shah DJ FAU - Thompson, Terry AU - Thompson T FAU - Drangova, Maria AU - Drangova M FAU - White, James A AU - White JA LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PT - Validation Study DEP - 20130404 PL - United States TA - J Magn Reson Imaging JT - Journal of magnetic resonance imaging : JMRI JID - 9105850 RN - 0 (Contrast Media) RN - AU0V1LM3JT (Gadolinium) SB - IM MH - Cardiomyopathies/*complications/*pathology MH - Contrast Media/administration & dosage MH - Female MH - Fibrosis MH - *Gadolinium/administration & dosage MH - Humans MH - Image Enhancement/*methods MH - Image Interpretation, Computer-Assisted/methods MH - Male MH - Middle Aged MH - Myocardial Ischemia/*complications/*pathology MH - Myocardium/*pathology MH - Reproducibility of Results MH - Retrospective Studies MH - Sensitivity and Specificity OTO - NOTNLM OT - late gadolinium enhancement OT - magnetic resonance imaging OT - quantitative analysis OT - visual quantification EDAT- 2013/04/06 06:00 MHDA- 2014/07/25 06:00 CRDT- 2013/04/06 06:00 PHST- 2011/12/16 00:00 [received] PHST- 2013/02/13 00:00 [accepted] PHST- 2013/04/06 06:00 [entrez] PHST- 2013/04/06 06:00 [pubmed] PHST- 2014/07/25 06:00 [medline] AID - 10.1002/jmri.24116 [doi] PST - ppublish SO - J Magn Reson Imaging. 2013 Dec;38(6):1369-76. doi: 10.1002/jmri.24116. Epub 2013 Apr 4.